Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bebtelovimab by Eli Lilly and Co for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Bebtelovimab is under clinical development by Eli Lilly and Co and currently in Phase III for Coronavirus Disease 2019 (COVID-19)....